Wharton' jelly mesenchymal stromal cell therapy for ischemic brain injury
Increasing evidence have supported that Wharton's jelly mesenchymal stem cell (WJ-MSCs) have immunomodulatory and protective effects against several diseases including kidney, liver pathologies, and heart injury. Few in vitro studies have reported that WJ-MSCs reduced inflammation in hippocampa...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Brain Circulation |
Subjects: | |
Online Access: | http://www.braincirculation.org/article.asp?issn=2394-8108;year=2018;volume=4;issue=3;spage=124;epage=127;aulast= |